首页 > 市场调查报告书 > 医疗设备

药物递输设备

注射笔市场规模、份额和成长分析（按类型、治疗方法、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1900455

注射笔市场规模、份额和成长分析（按类型、治疗方法、最终用户和地区划分）—2026-2033年产业预测

Injection Pen Market Size, Share, and Growth Analysis, By Type (Disposable Injection Pens, Reusable Injection Pens), By Therapy (Diabetes, Growth Hormone Therapy), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，注射笔市场规模将达到 524.2 亿美元，到 2025 年将达到 565.8 亿美元，到 2033 年将达到 1041.8 亿美元，预测期（2026-2033 年）的复合年增长率为 7.93%。

全球注射笔市场受到糖尿病、癌症等慢性病盛行率上升以及人口老化的显着影响。推动市场成长的关键因素包括人们对自行注射装置的认知度不断提高以及慢性病发病率的上升。糖尿病患者正迅速采用配备先进技术的可重复使用注射笔，尤其是那些透过蓝牙连接计算碳水化合物摄取量和胰岛素剂量的创新产品。此外，医疗专业人员也越来越倾向于使用自动注射笔，因为它们能够实现精准、安全、便利的给药。由于人口老化带来的慢性病风险增加，注射笔的需求不仅在已开发国家，而且在发展中地区也在成长。

注射笔市场按类型、治疗方法、最终用户和地区进行细分。依类型划分，注射笔分为一次性注射笔和可重复使用注射笔。治疗方法，注射笔可分为糖尿病治疗、生长激素荷尔蒙疗法、骨质疏鬆症治疗、不孕症治疗、肥胖症治疗和其他治疗方法。依最终使用者划分，注射笔可分为居家医疗机构和医院/诊所。依地区划分，注射笔可分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

注射笔市场成长要素

糖尿病、肥胖症和荷尔蒙失衡等疾病的日益普遍，显着推动了全球对注射笔的需求。随着越来越多的患者需要持续治疗，对易于使用、精准高效的自我注射装置的需求也日益增长。这些工具不仅有助于慢性病的管理，也能鼓励患者坚持处方治疗，最终改善健康。因此，由于日益注重健康的消费者对创新给药解决方案的需求，注射笔市场正经历显着成长。

制约注射笔市场的因素

口服药物和输液帮浦等替代给药方式的日益普及，对注射笔市场构成了重大挑战。随着患者和看护者优先考虑这些替代方式的便利性，注射笔的需求可能会下降，从而导致供应问题。这种偏好的转变可能会抑制注射笔类别的成长，因为注射笔难以与其他给药系统提供的便利性和易用性竞争。因此，随着消费者越来越不愿意选择传统的注射方式，注射笔市场可能会陷入停滞。

注射笔市场趋势

注射笔市场正呈现出显着的智慧型注射笔普及趋势，这类注射笔融合了先进技术，旨在提升患者照护。这些设备具备蓝牙连接和行动应用程式相容性，可为使用者提供即时用药监测，从而提高用药依从性，并促进患者与医护人员之间的沟通。这些智慧功能的整合不仅使患者能够更有效地管理治疗，也使医护人员能够根据精准数据追踪和调整治疗方案，最终提升注射笔市场的患者管理标准和治疗效果。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Novo Nordisk A/S（Denmark）
Eli Lilly And Company（US）
Sanofi（France）
Ypsomed Holding AG（Switzerland）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
AstraZeneca（UK）
Owen Mumford（UK）
Sun Pharmaceutical Industries Ltd（India）
Pfizer Inc.（US）
Biocon（India）
Lupin（India）
Wockhardt Ltd.（India）
Medtronic（US）
Gerresheimer AG（Germany）
Shaily Engineering Plastics Ltd.（India）
SHL Medical AG（Switzerland）
Emperra GmbH E-Health Technologies（Germany）
Nemera France SAS（France）
Jiangsu Delfu Medical Device Co., Ltd.（China）
Solteam Medical（China）
Stevanato Group（Italy）
Wanhai Medical Instruments Co., Ltd.（China）

简介目录

Product Code: SQMIG35A2646

Injection Pen Market size was valued at USD 52.42 Billion in 2024 and is poised to grow from USD 56.58 Billion in 2025 to USD 104.18 Billion by 2033, growing at a CAGR of 7.93% during the forecast period (2026-2033).

The global injection pen market is significantly influenced by the rising prevalence of chronic illnesses such as diabetes and cancer, coupled with an aging population. Key factors driving market growth include heightened awareness of self-injectable devices and the increasing incidence of chronic diseases. Notably, the use of reusable injectable pens featuring advanced technology is surging among diabetic patients, as seen with innovative products that calculate carbohydrate intake and insulin dosage through Bluetooth connectivity. Additionally, automated injection pens are gaining favor among healthcare providers for their ability to deliver medications with precision, safety, and convenience. The demand for injection pens is escalating not only in developed nations but also in developing regions, propelled by the vulnerability of the aging population to chronic health issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Injection Pen market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Injection Pen Market Segments Analysis

Injection Pen Market is segmented by Type, Therapy, End User, and region. Based on Type, the market is segmented into Disposable Injection Pens, and Reusable Injection Pens. Based on Therapy, the market is segmented into Diabetes, Growth Hormone Therapy, Osteoporosis, Fertility, Obesity, and Other Therapies. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Injection Pen Market

The growing prevalence of conditions such as diabetes, obesity, and hormonal imbalances is significantly boosting the global demand for injection pens. With more patients requiring ongoing treatment, there is an escalating need for user-friendly, precise, and efficient self-administration devices. These tools not only facilitate easier management of chronic diseases but also enhance patient adherence to prescribed therapies, ultimately leading to better health outcomes. As a result, the market for injection pens is experiencing substantial growth, driven by the necessity for innovative delivery solutions that meet the demands of an increasingly health-conscious population.

Restraints in the Injection Pen Market

The increasing availability of alternative drug delivery methods, such as oral medications and infusion pumps, poses a significant challenge to the injection pen market. As patients and caregivers prioritize the convenience and ease of these alternatives, the demand for injection pens may decline, leading to potential supply issues. This shift in preference could hinder the growth of the injection pen sector, as stakeholders might find it difficult to compete with the simplicity and user-friendliness offered by other delivery systems. Consequently, the injection pen market may experience stagnation due to a growing reluctance among consumers to choose traditional injection methods.

Market Trends of the Injection Pen Market

The Injection Pen market is witnessing a significant trend toward the rising adoption of smart injection pens, which incorporate advanced technology to enhance patient care. These devices, featuring Bluetooth connectivity and compatibility with mobile applications, provide users with real-time monitoring of medication usage, which improves adherence and fosters better communication between patients and healthcare providers. This integration of smart features not only empowers patients to manage their treatment more effectively but also allows healthcare professionals to track and adjust therapies based on precise data, ultimately elevating the standards of patient management and health outcomes in the injection pen market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Supply Chain Analysis
Trade Analysis
Value Chain Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Customer & Buying Criteria Analysis
Case Study Analysis

Injection Pen Market by Type

Market Overview
Disposable Injection Pens
Reusable Injection Pens

Injection Pen Market by Therapy

Market Overview
Diabetes
- Insulin
- Glucagon-Like Peptide-1
Growth Hormone Therapy
Osteoporosis
Fertility
Obesity
Other Therapies

Injection Pen Market by End User

Market Overview
Home Care Settings
Hospitals & Clinics

Injection Pen Market Size by Region

Market Overview
North America
- US
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly And Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocon (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shaily Engineering Plastics Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SHL Medical AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemera France SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Medical Device Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Medical (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wanhai Medical Instruments Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments